Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Online Adaptive Radiotherapy With Sequential Boost in Locally Advanced Rectal Cancer
NCT06246344Phase 3Active, not recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoint: Pathologic Complete Response. Started Dec 2023; status: active, not recruiting.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT06246344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06246344.